Physician profile
Michael J Lund
NPI 1659379394
$1,250.26
in general payments reported to CMS, 2019-2025
19 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2021: $88.58 · 2022: $76.09 · 2023: $145 · 2024: $310 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $333.06 | 2021-2025 | Rocklatan, Rhopressa, Centurion |
| Abbvie INC. | $138.07 | 2022-2024 | |
| Amgen INC. | $134.19 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $107.47 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $78.75 | 2025 | Xdemvy |
| Sight Sciences, INC. | $68.51 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $59.57 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $55.74 | 2019-2025 | |
| Optos, INC. | $55.03 | 2019 | |
| Horizon Therapeutics Plc | $40.03 | 2023 | Tepezza |
| Biotissue Holdings INC. | $32.71 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.16 | 2019-2021 | |
| Rxsight INC | $24.61 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Regeneron Healthcare Solutions, INC. | $22.81 | 2024 | Eylea, Eylea Hd |
| Omeros Corporation | $17.34 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $16.47 | 2023 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $13.60 | 2022 | |
| Aerie Pharmaceuticals, INC. | $12.70 | 2019 | |
| New World Medical,INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.